Low density of CD1+ cells in the synovial tissue of patients with rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 22, Issue 4, 2004, Pages 433-440

  Weidler, Claudia ^a   Kröll, Reinhold ^a   Miller, Luitpold E ^a   Schölmerich, Jürgen ^a   Grifka, Joachim ^a   Straub, Rainer H ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

CD1a; CD1b; CD1c; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

AZATHIOPRINE; CD1 ANTIGEN; GLYCOLIPID; GOLD; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; LEFLUNOMIDE; LYMPHOCYTE ANTIGEN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE; T6 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KNEE SURGERY; LYMPHOCYTE SUBPOPULATION; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NATURAL KILLER CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SEROLOGY; SYNOVIOCYTE; SYNOVITIS; SYNOVIUM; T LYMPHOCYTE; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD1; ARTHRITIS, RHEUMATOID; CELL COUNT; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; OSTEOARTHRITIS; SYNOVIAL MEMBRANE; T-LYMPHOCYTE SUBSETS;

EID: 4143109077     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. KEMPSELL KE, COX CJ, MCCOLM AA et al.: Detection of Mycobacterium tuberculosis group organisms in human and mouse joint tissue by reverse transcriptase PCR: prevalence in diseased synovial tissue suggests lack of specific association with rheumatoid arthritis. Infect human 2001; 69: 1821-31.
2. CHEN T, RIMPILAINEN M, LUUKKAINEN R et al.: Mononuclear cell response to enterobacteria and Gram-positive cell walls of normal intestinal microbiota in early rheumatoid arthritis and other inflammatory arthritides. Clin Exp Rheumatol 2002; 20: 193-200.
3. EBRINGER A, RASHID T, WILSON C: Rheumatoid arthritis: proposal for the use of antimicrobial therapy in early cases. Scand J Rheumatol 2003; 32: 2-11.
4. CARTY SM, SNOWDEN N, SILMAN AJ: Should infection still be considered as the most likely triggering factor for rheumatoid arthritis? J Rheumatol 2003; 30: 425-9.
5. SODERLIN MK, KAUTIAINEN H, PUOLAKKAINEN M et al.: Infections preceding early arthritis in southern Sweden: a prospective population-based study. J Rheumatol 2003; 30: 459-64.
6. RES PC, SCHAAR CG, BREEDVELD FC et al.: Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet 1988; 2: 478-80.
7. HOLOSHITZ J, KONING F, COLIGAN JE, DE BRUYN J, STROBER S: Isolation of CD4-CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature 1989; 339: 226-9.
8. TANAKA Y, SANO S, NIEVES E et al.: Non-peptide ligands for human gamma delta T cells. Proc Natl Acad Sci USA 1994; 91: 8175-9.
9. BECKMAN EM, PORCELLI SA, MORITA CT, BEHAR SM, FURLONG ST, BRENNER MB: Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 1994; 372: 691-4.
10. PORCELLI SA, MODLIN RL: The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 1999; 17: 297-329.
11. ZENG Z, CASTANO AR, SEGELKE BW, STURA EA, PETERSON PA, WILSON IA: Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. Science 1997; 277: 339-45.
12. SCHAIBLE UE, KAUFMANN SH: CD1 and CD1-restricted T cells in infections with intracellular bacteria. Trends Microbiol 2000; 8: 419-25.
13. MOODY DB, PORCELLI SA: Intracellular pathways of CD1 antigen presentation. Nat Rev Immunol 2003; 3: 11-22.
14. MOODY DB, REINHOLD BB, GUY MR et al.: Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 1997; 278: 283-6.
15. SHAMSHIEV A, DONDA A, CARENA I, MORI L, KAPPOS L, DE LIBERO G: Self glycolipids as T-cell autoantigens. Eur J Immunol 1999; 29: 1667-75.
16. MILLER LE, GRIFKA J, SCHÖLMERICH J, STRAUB RH: Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis. J Rheumatol 2002; 29: 427-35.
17. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
18. MILLER LE, JÜSTEN HP, SCHÖLMERICH J, STRAUB RH: The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 2000; 14: 2097-107.
19. STRAUB RH, GÜNZLER C, MILLER LE, CUTOLO M, SCHÖLMERICH J, SCHILL S: Anti-inflammatory cooperativity of corticosteroids and norepinephrine in rheumatoid arthritis synovial tissue in vivo and in vitro. FASEB J 2002; 16: 993-1000.
20. STRAUB RH, LANG B, FALK W, SCHÖLMERICH J, SINGER EA: In vitro superfusion method for the investigation of nerve-immune cell interaction in murine spleen. J Neuroimmunol 1995; 61:53-60.
21. STRAUB RH, PONGRATZ G, GÜNZLER C et al.: Immunoregulation of IL-6 secretion by endogenous and exogenous adenosine and by exogenous purinergic agonists in splenic tissue slices. J Neuroimmunol 2002; 125: 73-81.
22. CAULI A, PITZALIS C, YANNI G, AWAD M, PANAYI GS: CD1 expression in psoriatic and rheumatoid arthritis. Rheumatology (Oxford) 2000; 39: 666-73.
23. PAGE G, LEBECQUE S, MIOSSEC P: Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J Immunol 2002; 168: 5333-41.
24. MOODY DB, ULRICHS T, MUHLECKER W et al.: CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 2000; 404: 884-8.
25. BUCALA R, RITCHLIN C, WINCHESTER R, CERAMI A: Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med 1991; 173: 569-74.
26. XU WD, FIRESTEIN GS, TAETLE R, KAUSHANSKY K, ZVAIFLER NJ: Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest 1989; 83: 876-82.
27. OFFNER H, PEDERSEN FK, KONAT G: Lymphocyte stimulation by gangliosides, cerebrosides and basic protein in juvenile rheumatoid arthritis. J Clin Lab Immunol 1981; 6:35-7.
28. KOJO S, ADACHI Y, KEINO H, TANIGUCHI M, SUMIDA T: Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum 2001; 44: 1127-38.
29. ZEBALLOS RS, FOX RI, CHERESH DA, MCPHERSON RA: Anti-glycosphingolipid autoantibodies in rheumatologic disorders. J Clin Lab Anal 1994; 8: 378-84.
30. BANSAL AS, ABDUL-KARIM B, MALIK RA et al.: IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls. J Clin Pathol 1994; 47: 300-2.
31. SALIH AM, NIXON NB, GAGAN RM et al.: Anti-ganglioside antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy. Br J Rheumatol 1996; 35: 725-31.
32. RIVERO M, SANTIAGO B, GALINDO M, BREHMER MT, PABLOS JL: Cyclooxygenase-2 inhibition lacks immunomodulatory effects on T cells. Clin Exp Rheumatol 2002; 20: 379-85.
33. SERVITJE O, SERON D, FERRER I, CARRERA M, PAGEROLS X, PEYRI J: Quantitative and morphometric analysis of Langerhans cells in non-exposed skin in renal transplant patients. J Cutan Pathol 1991; 18: 106-11.
34. NURMENNIEMI PK, PERNU HE, KNUUTTILA ML: Density of CD1a-labeled Langerhans' cells in normal human gingiva and in nifedipine- and immunosuppressive medication-induced gingival overgrowth. J Periodontol 1999; 70:752-6.
35. THOMSON AW, NALESNIK MA, RILO HR, WOO J, CARROLL PB, VAN THIEL DH: ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. Autoimmunity 1993; 15: 215-23.